Bard Power Port Lawsuit Updates
Judge Sets Key Deadlines in Case Management Order
Judge Campbell has issued a new Case Management Order outlining critical deadlines for the ongoing litigation. Defendants must submit expert reports by May 23, 2025, with plaintiffs’ rebuttal reports due by June 20, 2025. All depositions must be completed by August 22, 2025, and motions to exclude expert testimony are due in September 2025. Additionally, both parties are required to meet and confer by April 21, 2025, to discuss the selection of bellwether plaintiffs. These deadlines ensure structured progress in the case.
Key Developments in Bard MDL
The Bard Implanted Port Catheter litigation advances with the fifteenth case management conference set for Thursday. Attorneys must submit a memorandum outlining key milestones, including discovery, expert reports, and motions. Discovery disputes persist, with delays in document production and interrogatory responses. Plaintiffs’ attorneys can now attend Bard sales representative depositions, potentially revealing internal knowledge of product risks. The court ordered Bard to produce missing complaint files in eighteen cases. Bard also seeks to recover legal fees from plaintiffs for delayed profile forms, a request under court review. Bellwether trials remain a key focus as litigation progresses.
Bard Implanted Port MDL Continues
The Bard Implanted Port Catheter MDL continues to advance. The Fourteenth Case Management Conference was held on February 20, 2025, with the next scheduled for March 20. A joint memorandum outlining key litigation milestones is due by March 18. The court addressed discovery delays and ordered Bard to produce the required complaint files. The plaintiffs’ counsel secured the right to attend Bard sales representative depositions in person. Some plaintiffs face dismissal for failing to submit required forms. Bard is also seeking to recover legal fees for delayed filings, with the court allowing further briefing before making a decision.
FDA Warns of Serious Risks Linked to Bard Rotarex Catheters
The FDA has issued a safety alert regarding a critical defect in Bard Peripheral Vascular’s Rotarex Atherectomy System, used to remove blood clots. According to the February 6 warning, the catheter’s rotating tip may fracture due to wear, friction, or high stress, posing a risk of severe injury or death. FDA reports cite 115 incidents requiring medical intervention, including 30 serious injuries and four fatalities. The Rotarex system’s rotating helix tip is designed to clear arterial blockages, but its structural failure raises significant safety concerns for healthcare providers and patients alike.
Catheter System AlertAbout The Bard PowerPort Lawsuit
The Bard PowerPort is a medical device used for patients needing frequent intravenous treatments. The device has been linked to serious complications in many patients. The port is designed to provide easy access to medication, fluids, and blood draws. However, many patients have reported suffering from severe injuries when the Bard PowerPort malfunctions such as infections, breaks, or migrations.
If you or a loved one has suffered from complications related to a Bard PowerPort, you may be entitled to compensation. Participating in the Bard PowerPort lawsuit can help you seek justice and hold the manufacturers accountable.
What Companies Are Involved?
C.R. Bard, the manufacturer of the PowerPort, is being sued for failing to properly warn patients and medical professionals about the risks associated with the port device. Many lawsuits claim that Bard was aware of the potential dangers but continued to market and sell the product to the healthcare facilities and patients without adequate safety warnings.
As more cases emerge, the fight for accountability is growing stronger. If you or a loved one has suffered from Bard PowerPort complications, you may be eligible to participate with others who are seeking justice and compensation.
Who Qualifies for the Bard PowerPort Lawsuit?
To participate in a Bard PowerPort lawsuit you’ll need to meet certain conditions such as:
- Implant of a Bard Powerport.
- Provide medical records showing that you received the port as a part of a medical treatment.
- Have medical documentation to connect your health problems to the PowerPort.
You may also be eligible if you have suffered from the following injury(ies):
- Blood Clots
- Cardiac Arrhythmia or Symptoms similar to a heart attack
- Cardiac Punctures
- Cardiac/pericardial Tamponade
- Migration due to breakage
- Hemorrhage/Hematoma
- Leakage at the port site
- Laceration to blood vessels
- Necrosis (Dead Tissue)
- Pulmonary Embolism (PE)
- Severe and Persistent Pain around the port/catheter
- Catheter Break (Into two or more pieces)
- Fracture (Remains one piece, no separation)
- Fractured pieces became embedded in the artery/organ.
- Fracture with pieces that broke apart and passed through the heart.
- Infection with the removal of the catheter.
- Blood Clots with Immediate Removal of Port.
- Death
We encourage you to seek legal advice to determine your eligibility. Various factors impact eligibility and all cases are unique.
How Much Compensation Can You Expect in a Bard PowerPort Lawsuit?
The settlement amount in a Bard PowerPort lawsuit can vary depending on several factors:
- The severity of your injury from the port.
- Strength of your evidence showing the port is to blame for your health-related problems.
Determining a typical settlement amount in a Bard PowerPort lawsuit can be a complicated process. At this point, Bard PowerPort lawsuits are still in the early stages, and no global settlements or jury trials have taken place. Many factors influence each case. These factors include the severity of the complications, the strength of the medical evidence, jury decisions, and the expertise of your legal team.
It's time to act now, if you or a loved one has experienced health complications due to a Bard PowerPort. Contact us today to learn more about your options and whether you pre-qualify to join the lawsuit. Seeking justice can not only provide you with potential financial compensation, but also hold the manufacturers accountable for the harm caused.
Add Comment